Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Open Access
- 1 November 2010
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (11), 4129-4140
- https://doi.org/10.1172/jci41732
Abstract
Activation of hepatic stellate cells in response to chronic inflammation represents a crucial step in the development of liver fibrosis. However, the molecules involved in the interaction between immune cells and stellate cells remain obscure. Herein, we identify the chemokine CCL5 (also known as RANTES), which is induced in murine and human liver after injury, as a central mediator of this interaction. First, we showed in patients with liver fibrosis that CCL5 haplotypes and intrahepatic CCL5 mRNA expression were associated with severe liver fibrosis. Consistent with this, we detected Ccl5 mRNA and CCL5 protein in 2 mouse models of liver fibrosis, induced by either injection of carbon tetrachloride (CCl4) or feeding on a methionine and choline–deficient (MCD) diet. In these models, Ccl5–/– mice exhibited decreased hepatic fibrosis, with reduced stellate cell activation and immune cell infiltration. Transplantation of Ccl5-deficient bone marrow into WT recipients attenuated liver fibrosis, identifying infiltrating hematopoietic cells as the main source of Ccl5. We then showed that treatment with the CCL5 receptor antagonist Met-CCL5 inhibited cultured stellate cell migration, proliferation, and chemokine and collagen secretion. Importantly, in vivo administration of Met-CCL5 greatly ameliorated liver fibrosis in mice and was able to accelerate fibrosis regression. Our results define a successful therapeutic approach to reduce experimental liver fibrosis by antagonizing Ccl5 receptors.Keywords
This publication has 45 references indexed in Scilit:
- Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and HumansGastroenterology, 2009
- A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionJournal of Hepatology, 2008
- Immune Interactions in Hepatic FibrosisClinics in Liver Disease, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- A second generation human haplotype map of over 3.1 million SNPsNature, 2007
- CCR5 Deficiency Drives Enhanced Natural Killer Cell Trafficking to and Activation within the Liver in Murine T Cell-Mediated HepatitisThe American Journal of Pathology, 2007
- Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organJCI Insight, 2007
- CCL3/MIP‐1α is pro‐inflammatory in murine T cell‐mediated hepatitis by recruiting CCR1‐expressing CD4+ T cells to the liverEuropean Journal of Immunology, 2004
- A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype DataAmerican Journal of Human Genetics, 2003